Qingdao, ChinaMOU · SAMPLE
Phase 1 · Bulk & local filling
IP-DRIVEN CLEAN BIO PLATFORM
THE GLOBAL BIO PLATFORM
Powered by proprietary technology, scalable IP, manufacturing capability and global commercialization.
Not Just Cosmetics. Building the Future of Bio-Care.
Technology01
IP Portfolio02
Manufacturing03
Global Commercialization04
GLOBAL BIO PLATFORM
Technology becomes a global bio-care ECO-SYSTEM.
HANKEI CORPORATE INFRASTRUCTURETechnology, manufacturing and global execution in one platform.
COMPANY OVERVIEW
An IP-driven clean bio platform company.
HANKEI connects proprietary clean bio technology, scalable IP, production capability and global commercialization into a single corporate platform designed for partners, investors and future B2B & D2C growth.
IPTechnology & rights
R&DMaterial platform
GLOBALLicensing & JV
01
Technology
Proprietary natural extraction and clean bio platform foundation.
02
IP Portfolio
Scalable intellectual property and commercialization rights.
03
Manufacturing
Production, formulation, quality control and supply system.
04
Global Network
D2C, OEM/ODM, licensing, JV and regional expansion.
Technology
→
IP
→
Products
→
Global Bio-Care
COSME NUEVO
A NEW ERA OF BIO CARE
Cosme Nuevo expresses HANKEI's vision to open a new category beyond conventional cosmetics — where clean bio technology, natural complex materials and global product scalability converge.
TECHNOLOGY & IP
Core technology first. Products second.
CA-NCRM-12™ and Zero Water positioning serve as the technology layer that supports ingredient development, formulation expansion, licensing and global commercialization.
CA-NCRM-12™
Natural medicinal plant complex material platform.
Zero Water
Positioned as a future-oriented clean bio-care base.
IP Strategy
Technology rights, licensing and commercialization structure.
Scale-up
From material technology to product and global execution.
SOURCE-BASED PLANNING DATA
CORE MATERIAL PLATFORM
CA-NCRM-12™
12
A natural medicinal plant complex platform designed as the starting point for water-replacement formulations, material development and multi-industry commercialization.
One-Step Extraction
Water Replacement
Preservative-Free Capable
Licensing & JV Transfer
TRL 9Commercialization readiness
200+Formulation & product recipes
70+Material references
TI-3TCB rating reference
R&D / MANUFACTURING
From laboratory concept to production architecture.
HANKEI's platform story connects R&D assets, factory capability, product categories and global commercialization into one integrated IR narrative.
PRODUCT PLATFORM
Products are the visible layer of the platform.
IR introduces the product portfolio, while purchase conversion is connected to the official D2C mall and partner channels.
RECURRING REVENUE MODEL
One platform. Multiple revenue layers.
The JV model is designed to move beyond finished-product sales into equipment, raw materials, bulk supply, equity dividends and technology royalties. All figures and contract statuses shown in this prototype require final verification.
01Equipment Supply
Extraction, filling and packaging lines.
→
02Raw Material
Standardized natural functional materials.
→
03Bulk Supply
Korea-made bulk, local filling and sales.
→
04Equity Dividend
JV operating profit and shareholder returns.
→
05Technology Royalty
Recurring IP licensing and technical support.
GLOBAL COMMERCIALIZATION
Technology expands through licensing, JV and global distribution.
A standardized JV technical collaboration system connects Korea HQ technology with local natural resources, production infrastructure and regional distribution.
2026-2027 CONTRACT & EXECUTION TARGET
Global Expansion Map · JV Technical Collaboration
Status, resource and phase information must be replaced with approved contract data before public release.
Yanji, ChinaRESTARTING
Perilla · plant Omega-3 extraction
Phase 2 · Equipment & technology transfer
Tashkent, UzbekistanUNDER DISCUSSION
Pomegranate / herbal plants: functional ingredients
Partner & line selection
Alexandria, EgyptMOU · SAMPLE
Date palm fruit / herbal plants: functional ingredients
Phase 1 · Bulk & distribution
Ho Chi Minh, VietnamPRELIMINARY
Ngoc Linh ginseng · functional extraction
Phase 1→2 · Bulk to extraction platform
Ulaanbaatar, MongoliaUNDER DISCUSSION
Medicinal herb ingredients: functional ingredients
Feasibility review
Mumbai, IndiaUNDER DISCUSSION
Ayurvedic plant ingredients: functional ingredients
Partner discovery
Mombasa, KenyaUNDER DISCUSSION
Medicinal herb ingredients: functional ingredients
Market & resource review
IP-CENTERED GOVERNANCE
Technology is controlled centrally. Business scales globally.
HANKEI Holdings is presented as the IP control tower, while R&D, supply chain, production, sales subsidiaries and overseas JV entities operate the business. This is a target structure, not the current legal organization chart.
LISTING ENTITY · TARGET
HANKEI Holdings
IP · Licensing · Global Strategy · IR · Governance
R&D
Research Entity
Technology upgrade · Clinical · Patent expansion
SUPPLY
Material Entity
Extraction · Standardization · B2B materials
PRODUCTION
Manufacturing Entity
OEM/ODM · QA/QC · Scale-up
SALES
Category Subsidiaries
D2C · B2B · Brand & channel operation
GLOBAL JV
Local JV Entities
Local production · Distribution · Royalty
2026Single entity + contract-managed JV
2027Material and manufacturing entity separation
2028+Category spin-offs and regional hubs
LEADERSHIP & HUMAN CAPITAL
One leader aligning corporate strategy and core technology.
HANKEI integrates the CEO and CTO roles under one executive leader, enabling faster alignment across strategy, IP, technology commercialization and global execution.
UNIFIED EXECUTIVE LEADERSHIP
CEOCTO
CHIEF EXECUTIVE OFFICER & CHIEF TECHNOLOGY OFFICERChoo Min-chul, Ph.D.
He unifies corporate strategy and core technology leadership, connecting IP governance, global execution and technology commercialization within one decision-making structure.
Nanomaterials research and technology commercialization
Focused ultrasound dispersion and emulsion platform
Technology alignment for premium pipeline expansion
Corporate direction, IP governance, global JV structure and Pre-IPO readiness.
SFFE, nano dispersion, surfactant-free emulsion and Cerium Oxide application technologies.
Links R&D, manufacturing, partner strategy and international expansion into one leadership flow.
Technology / R&D
Extraction, formulations, nano-dispersion, clinical and patent expansion.
Core specialist personnel deploymentManufacturing / QA
Scale-up, SOP, QA/QC and global production transfer.
Factory scale-upGlobal JV / Licensing
Contract, partner, country launch and royalty management.
Regional specialist poolFinance / IR / Listing
K-IFRS, investment, disclosure, TCB and KOSDAQ readiness.
Pre-IPO functionFINANCIAL HIGHLIGHTS · MANAGEMENT TARGET
Growth targets supported by a differentiated cost structure.
All financial figures below are prototype targets extracted from supplied planning materials. They are not audited results and must be reconciled with the final financial model before publication.
2026 SALES TARGETKRW 17.0BConservative figure
2027 SALES TARGETKRW 35.0BConservative figure
OPERATING MARGIN53%+Management target
JV MARGIN70%+Scenario target
ONE-STEP EXTRACTION COST LOGIC
Less raw material. Fewer post-processes. Higher scalability.
* Illustrative comparison based on producing one ton of extract.
KOSDAQ LISTING ROADMAP
Technology listing readiness connected to execution milestones.
This timeline is a planning prototype. Advisors, underwriters, ratings, investment and filing dates must be updated only after formal approval or contract execution.
Foundation & Re-evaluation
- TCB TI-3 reference · TI-2/TI-1 target review
- K-IFRS conversion advisory · under review
- Factory scale-up and premium product launch
Pre-IPO & Global Execution
- Lead underwriter selection · candidate review
- Pre-IPO funding and production capacity expansion
- JV definitive contracts and overseas entity setup
Technology Listing Review
- Technology assessment and listing structure confirmation
- Preliminary listing application target
- Disclosure, governance and internal control completion
CERTIFICATES & TEST REPORTS
Verification-driven technical barrier to entry
The previous celebrity/marketing-oriented media area has been converted into a document archive prototype. Every card is currently a placeholder until the original certificate or report PDF is approved for publication.
Technology Grade
TI-3Antibacterial Test
99.9%Deodorization Test
96%Skin Irritation Index
0.00Regulatory Archive
SASO · NMPA · SFDAPatent & Trademark Portfolio
ORIGIN PATENT · FORMULATION PATENT · TRADEMARKSINVESTOR RELATIONS
A structured IR gateway for investors and partners.
Business, financial, listing, certificate and controlled data-room content are separated for future CMS operation.
01
Business Overview
Platform and recurring revenue architecture.
02Financial Highlights
Management targets and cost logic.
03Listing Roadmap
Technology listing readiness milestones.
04Certificates & Reports
Proof archive
05
IR Presentation
Company deck
06
Controlled Data Room
Approval-certified view
IR 자료
등록된 실적발표 자료가 없습니다분기·연간 실적 발표자료는 준비되는 대로 이곳에 게시됩니다.
등록된 사업보고서가 없습니다사업보고서는 준비되는 대로 이곳에 게시됩니다.
등록된 영업보고서가 없습니다영업보고서는 준비되는 대로 이곳에 게시됩니다.
등록된 기타 IR자료가 없습니다기타 IR자료는 준비되는 대로 이곳에 게시됩니다.
IR 자료
CONTACT
Route every inquiry through one official channel.
IR InquiryInvestmentBusiness / JVOEM / ODM